Focus FlowADHD in Adults: Can a Phone App Replace a Therapist?
Why Medication Isn't the Answer for Everyone
The primary treatment for adult ADHD is medication, usually stimulants. They are indeed effective, but the statistics are sobering: only about 30% of patients receive pharmacotherapy, and fewer than 3% have access to psychotherapy. Yet clinical guidelines are clear: treatment should be comprehensive — medication, skills training, and psychoeducation.
The problem isn't that effective methods don't exist. The problem is access. There are few specialists, wait times are long, and many people live far from major cities where most clinics are concentrated. This is where digital solutions enter the picture.
ORIKO: 12 Weeks of Therapy in Your Pocket
German researchers from several leading university hospitals developed the ORIKO app — a self-help program for adults with ADHD. This isn't another habit tracker or productivity calculator. It's a full therapeutic course built on the same methods psychotherapists use in their offices: cognitive behavioral therapy, dialectical behavior therapy, and social skills training.
The program consists of 12 sequential modules. Each includes short videos featuring doctors, psychotherapists, and people with ADHD, plus practical exercises for everyday life. Here's what the course covers:
- Attention and focus — how to maintain concentration when your brain wants to switch to everything at once
- Organization and structure — practical tools for planning your day without perfectionism
- Time perception — why five minutes can feel like thirty seconds for someone with ADHD, and what to do about it
- Impulse control — "pause" techniques before impulsive decisions
- Emotion regulation — how to keep emotional waves from driving your behavior
- Procrastination and avoidance — breaking the vicious cycle of "I don't want to — I won't — I feel guilty"
- Social interaction — how to improve communication when ADHD makes it hard to listen and wait your turn
- Sleep and recovery — why quality sleep is critically important with ADHD
An important detail: the app works without a therapist. It's a fully self-guided program — which is exactly why it can be available to an unlimited number of people simultaneously.
The Pilot Study Is Done. Now — the Big Test
A preliminary small-scale study of ORIKO already showed encouraging results: improved quality of life and reduced ADHD symptoms. But a pilot study is like a first test drive. To prove the app truly works, a full-scale clinical trial is needed.
That's exactly what's happening now. A team from eight German university hospitals launched a large-scale randomized controlled trial — the gold standard in medical research. 380 adults with confirmed ADHD diagnoses will be randomly assigned to two groups: one receives immediate access to the app, the other continues usual treatment and receives the app after the study concludes.
Over 12 weeks, researchers will track not just ADHD symptoms, but a whole spectrum of outcomes: quality of life, depression, anxiety, substance use, daily functioning ability, and even health literacy levels.
Why This Matters for Everyone
If the study confirms ORIKO's effectiveness, it could change the approach to adult ADHD treatment in several important ways:
Accessibility. The app doesn't depend on therapist availability, geography, or time of day. Someone in a small town has the same access to therapy as a resident of Berlin or Hamburg.
Scalability. A single app can simultaneously serve thousands of users. Compare that to a single therapist who can physically see 20-30 patients per week.
Complement to medication. For those already taking medication, the app could become that "second component" of comprehensive treatment that's so often missing. And for those who don't want or can't take medication — an alternative.
Lower barrier to entry. No need to go anywhere, sit in a waiting room, or explain your situation to a stranger. Open the app — and work at your own pace.
But There Are Caveats
Let's be realistic. The app isn't a magic wand. Participants can't be "blinded" (they know whether they received the app or not), which may influence expectations. All data are self-reports, without clinician assessment. And, as often happens with digital tools, some people will inevitably drop out before completing the course — especially when the target audience consists of people who by definition struggle to finish things.
Additionally, the study won't answer whether results are maintained long-term. But it's a first step.
Instead of a Summary
We live in an era when a smartphone can measure your pulse, remind you about medication, and teach you to meditate. Can it also help millions of adults with ADHD access therapy they've been waiting years for? We'll find out very soon. And if the answer is yes, this could become one of the most important steps toward truly accessible mental health care.